公开(公告)号：US20250049389A1

公开(公告)日：2025-02-13

申请号：US18925856

申请日：2024-10-24

Applicant: MEDTRONIC, INC.

Inventor： Vinod Sharma ,  Eduardo N. Warman ,  Shantanu Sarkar ,  Tommy D. Bennett ,  Lindsay M. Streeter ,  Jennifer K. Bravinder

IPC: A61B5/00 ,  A61B5/0205 ,  A61B5/021 ,  A61B5/0215 ,  A61B5/053 ,  A61B5/07 ,  A61J1/00 ,  A61N1/362 ,  A61N1/365 ,  A61N1/39 ,  G01G19/44 ,  G16H20/10 ,  G16H20/13 ,  G16H40/40 ,  G16H40/63 ,  G16H40/67 ,  G16H50/30

Abstract: Methods and systems for seamless adjustment of treatment are disclosed. A determination is made as to whether to intervene with a patient's treatment. Implanted device memory data is acquired over a pre-specified time period. Risk status is determined from the device memory data. Another external device memory data is acquired over a pre-specified time period. A determination is made as to whether to adjust treatment of the patient in response to the risk status, the data acquired from the implanted device memory and the external device memory data.

公开(公告)号：US12226226B2

公开(公告)日：2025-02-18

申请号：US16922326

申请日：2020-07-07

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma ,  Eduardo N. Warman ,  Shantanu Sarkar ,  Tommy D. Bennett ,  Lindsay M. Streeter ,  Jennifer K. Bravinder

IPC: A61B5/00 ,  A61B5/0205 ,  A61B5/07 ,  G16H20/10 ,  G16H40/40 ,  G16H40/63 ,  G16H50/30 ,  A61B5/021 ,  A61B5/0215 ,  A61B5/053 ,  A61J1/00 ,  A61N1/362 ,  A61N1/365 ,  A61N1/39 ,  G01G19/44 ,  G16H20/13 ,  G16H40/67

Abstract: Methods and systems for seamless adjustment of treatment are disclosed. A determination is made as to whether to intervene with a patient's treatment. Implanted device memory data is acquired over a pre-specified time period. Risk status is determined from the device memory data. Another external device memory data is acquired over a pre-specified time period. A determination is made as to whether to adjust treatment of the patient in response to the risk status, the data acquired from the implanted device memory and the external device memory data.

公开(公告)号：US11116456B2

公开(公告)日：2021-09-14

申请号：US16454679

申请日：2019-06-27

Applicant: Medtronic, Inc.

Inventor： Douglas A. Hettrick ,  John E. Burnes ,  Tommy D. Bennett ,  Shantanu Sarkar ,  Eduardo N. Warman ,  Todd M. Zielinski

IPC: A61B5/00 ,  A61B5/021 ,  A61B5/0295 ,  A61B5/053 ,  A61B5/0538 ,  A61B5/07 ,  A61N1/365 ,  A61N1/372 ,  A61N1/375

Abstract: In some examples, determining a heart failure status of a patient using a medical device comprising a plurality of electrodes includes determining an estimated arterial pressure waveform of the patient based on an arterial impedance signal received from at least two of the plurality of electrodes. The estimated arterial pressure waveform may comprise a plurality of arterial pressure cycles. Each of the plurality of arterial pressure cycles may correspond to a different cardiac cycle of a plurality of cardiac cycles of the patient. At least one value of an intrinsic frequency of the corresponding arterial pressure cycle may be determined for at least some of the plurality of cardiac cycles and the heart failure status of the patient may be determined based on the at least one value of the intrinsic frequency.

公开(公告)号：US20160213265A1

公开(公告)日：2016-07-28

申请号：US15090105

申请日：2016-04-04

Applicant: Medtronic, Inc.

Inventor： Sarah A. Audet ,  James K. Carney ,  William J. Combs ,  Tommy D. Bennett ,  Barbro M.L. Kjellstrom

IPC: A61B5/0205 ,  A61B5/00

CPC classification number: A61B5/02055 ,  A61B5/0215 ,  A61B5/4836 ,  A61B5/686 ,  A61B5/7203 ,  A61N1/36514 ,  A61N1/36564 ,  A61N1/37258

Abstract: The present disclosure provides an apparatus and method of detecting ischemia with a pressure sensor. The method can include obtaining a pressure signal and determining a pressure rate of change. The method can also include identifying at least one of impaired relaxation and impaired contractility in order to detect ischemia.

Abstract translation: 本公开提供了利用压力传感器检测缺血的装置和方法。 该方法可以包括获得压力信号并确定压力变化率。 该方法还可以包括鉴定减轻的松弛和受损的收缩力中的至少一种以便检测缺血。

公开(公告)号：US20180168461A1

公开(公告)日：2018-06-21

申请号：US15385042

申请日：2016-12-20

Applicant: Medtronic, Inc.

Inventor： Mary M. Morris ,  Ruth N. Klepfer ,  Tommy D. Bennett

IPC: A61B5/0215 ,  A61B5/00 ,  A61B5/0205 ,  A61N1/362 ,  A61N1/365 ,  A61N1/39

CPC classification number: A61B5/0215 ,  A61B5/0031 ,  A61B5/0205 ,  A61B5/02156 ,  A61B5/1072 ,  A61B5/1075 ,  A61B5/11 ,  A61B5/1116 ,  A61B5/686 ,  A61B5/7275 ,  A61B5/74 ,  A61B5/7475 ,  A61B2560/0238 ,  A61N1/3621 ,  A61N1/36564 ,  A61N1/3987

Abstract: A method for monitoring a cardiovascular pressure in a patient may include storing, in a memory of an implantable medical device system and in association with each one or more different patient postures, a respective offset value for the cardiovascular pressure of the patient. The one or more offset values may be determined based on a distance between an implantable pressure sensing device and an anatomical structure of the patient, a location of the implantable pressure sensing device within the patient, or one or more dimensions an anatomical structure of the patient. The method further includes determining a measured value of the cardiovascular pressure and a posture of the patient when the value of the cardiovascular pressure was measured, selecting a stored offset value associated with the current patient posture, and determining an adjusted cardiovascular pressure value based on the selected offset value and the measured cardiovascular pressure value.

公开(公告)号：US09943633B2

公开(公告)日：2018-04-17

申请号：US15190553

申请日：2016-06-23

Applicant: Medtronic, Inc.

Inventor： Daniel C. Sigg ,  Sarah Anne Audet ,  Tommy D. Bennett ,  Dwight H. Warkentin

IPC: A61M37/00 ,  A61M1/34 ,  A61M1/16 ,  A61M1/36

CPC classification number: A61M1/3403 ,  A61M1/16 ,  A61M1/34 ,  A61M1/3406 ,  A61M1/341 ,  A61M1/36 ,  A61M1/3669 ,  A61M2205/18 ,  A61M2205/33 ,  A61M2205/3334 ,  A61M2205/3344 ,  A61M2205/3523 ,  A61M2205/50 ,  A61M2205/502 ,  A61M2205/52 ,  A61M2230/005 ,  A61M2230/04 ,  A61M2230/20 ,  A61M2230/201 ,  A61M2230/30 ,  A61M2230/65

Abstract: A medical device system including a physiological sensor and ultrafiltration unit senses a physiological signal in a patient and computes a fluid status measurement of the patient using the physiological signal. Ultrafiltration therapy is delivered to the patient according to a therapy delivery control parameter established in response to the fluid status measurement.

公开(公告)号：US20220323007A1

公开(公告)日：2022-10-13

申请号：US17808924

申请日：2022-06-24

Applicant: Medtronic, Inc.

Inventor： Jonathan L. Kuhn ,  James K. Carney ,  Vinod Sharma ,  Shantanu Sarkar ,  Todd M. Zielinski ,  Tommy D. Bennett

IPC: A61B5/00 ,  A61B5/0205 ,  A61B5/07 ,  A61B5/1455 ,  A61B5/1459 ,  A61B5/287

Abstract: In some examples, determining a heart failure status includes using an implantable medical device configured for subcutaneous implantation and comprising a plurality of electrodes and an optical sensor. Processing circuitry of a system comprising the device may determine, for a patient, a current tissue oxygen saturation value based on a signal received from the at least one optical sensor, a current tissue impedance value based on a subcutaneous tissue impedance signal received from the electrodes, and a current pulse transit time value based on a cardiac electrogram signal received from the electrodes and at least one of the signal received from the optical sensor and the subcutaneous tissue impedance signal. The processing circuitry may further compare the current tissue oxygen saturation value, current tissue impedance value, and current pulse transit time value to corresponding baseline values, and determine the heart failure status of the patient based on the comparison.

公开(公告)号：US20190336076A1

公开(公告)日：2019-11-07

申请号：US15969369

申请日：2018-05-02

Applicant: Medtronic, Inc.

Inventor： Jonathan L. Kuhn ,  James K. Carney ,  Vinod Sharma ,  Shantanu Sarkar ,  Todd M. Zielinski ,  Tommy D. Bennett

IPC: A61B5/00 ,  A61B5/0205 ,  A61B5/042 ,  A61B5/07 ,  A61B5/1455 ,  A61B5/1459

Abstract: In some examples, determining a heart failure status includes using an implantable medical device configured for subcutaneous implantation and comprising a plurality of electrodes and an optical sensor. Processing circuitry of a system comprising the device may determine, for a patient, a current tissue oxygen saturation value based on a signal received from the at least one optical sensor, a current tissue impedance value based on a subcutaneous tissue impedance signal received from the electrodes, and a current pulse transit time value based on a cardiac electrogram signal received from the electrodes and at least one of the signal received from the optical sensor and the subcutaneous tissue impedance signal. The processing circuitry may further compare the current tissue oxygen saturation value, current tissue impedance value, and current pulse transit time value to corresponding baseline values, and determine the heart failure status of the patient based on the comparison.

公开(公告)号：US20170245794A1

公开(公告)日：2017-08-31

申请号：US15402839

申请日：2017-01-10

Applicant: Medtronic, Inc.

Inventor： Vinod Sharma ,  Eduardo N. Warman ,  Shantanu Sarkar ,  Tommy D. Bennett ,  Lindsay M. Streeter ,  Jennifer K. Bravinder

IPC: A61B5/00 ,  A61J7/04 ,  A61J7/00 ,  A61B5/07 ,  A61B5/0205

CPC classification number: A61B5/4839 ,  A61B5/0205 ,  A61B5/021 ,  A61B5/0215 ,  A61B5/053 ,  A61B5/076 ,  A61B5/4842 ,  A61B5/4848 ,  A61B5/4878 ,  A61B5/686 ,  A61B5/6869 ,  A61B5/6876 ,  A61B5/7275 ,  A61B5/7282 ,  A61B5/742 ,  A61B2560/0475 ,  A61J1/00 ,  A61N1/3627 ,  A61N1/36521 ,  A61N1/36564 ,  A61N1/3956 ,  G01G19/44 ,  G16H20/13 ,  G16H40/40 ,  G16H40/63 ,  G16H40/67 ,  G16H50/30

Abstract: Methods and systems for seamless adjustment of treatment are disclosed. A determination is made as to whether to intervene with a patient's treatment. Implanted device memory data is acquired over a pre-specified time period. Risk status is determined from the device memory data. Another external device memory data is acquired over a pre-specified time period. A determination is made as to whether to adjust treatment of the patient in response to the risk status, the data acquired from the implanted device memory and the external device memory data.